CREDIT SUISSE AG/ - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$7,206,263
+5.1%
80,445
-0.1%
0.01%0.0%
Q2 2023$6,855,728
+15.2%
80,523
+11.9%
0.01%
+16.7%
Q1 2023$5,953,035
+9.7%
71,940
+4.3%
0.01%0.0%
Q4 2022$5,424,412
+33.2%
68,969
+25.4%
0.01%
+20.0%
Q3 2022$4,073,000
+24.7%
55,017
+9.8%
0.01%
+66.7%
Q2 2022$3,267,000
-0.9%
50,128
-3.9%
0.00%0.0%
Q1 2022$3,298,000
+27.3%
52,182
+6.8%
0.00%
+200.0%
Q4 2021$2,591,000
-39.2%
48,860
-19.1%
0.00%
-50.0%
Q3 2021$4,262,000
-17.0%
60,386
-21.5%
0.00%
-33.3%
Q2 2021$5,133,000
-22.5%
76,938
+29.0%
0.00%0.0%
Q1 2021$6,621,000
-72.4%
59,634
-70.4%
0.00%
-75.0%
Q4 2020$23,957,000
+86.3%
201,752
+36.9%
0.01%
+50.0%
Q3 2020$12,857,000
+69.9%
147,363
+74.4%
0.01%
+60.0%
Q2 2020$7,567,000
-76.6%
84,514
-73.9%
0.01%
-82.1%
Q1 2020$32,280,000
+79.8%
323,900
+107.3%
0.03%
+115.4%
Q4 2019$17,956,000
+156.1%
156,274
+181.2%
0.01%
+116.7%
Q3 2019$7,011,000
-9.7%
55,579
-13.8%
0.01%
-14.3%
Q2 2019$7,762,000
-8.8%
64,504
-33.7%
0.01%
-12.5%
Q1 2019$8,515,000
-0.3%
97,327
+14.1%
0.01%
-11.1%
Q4 2018$8,537,000
-37.6%
85,329
-28.5%
0.01%
-25.0%
Q3 2018$13,677,000
+21.6%
119,370
-4.8%
0.01%
+9.1%
Q2 2018$11,248,000
+56.4%
125,426
+27.6%
0.01%
+57.1%
Q1 2018$7,191,000
+38.3%
98,275
+9.8%
0.01%
+40.0%
Q4 2017$5,198,000
+5.6%
89,514
-18.4%
0.01%0.0%
Q3 2017$4,923,000
+65.3%
109,719
+45.5%
0.01%
+66.7%
Q2 2017$2,978,000
-1.5%
75,411
+1.3%
0.00%0.0%
Q1 2017$3,022,000
-7.7%
74,468
-8.5%
0.00%0.0%
Q4 2016$3,273,000
+51.9%
81,407
+36.9%
0.00%
+50.0%
Q3 2016$2,155,000
+39.5%
59,485
+11.6%
0.00%0.0%
Q2 2016$1,545,000
+27.8%
53,324
+54.2%
0.00%
+100.0%
Q1 2016$1,209,000
-24.3%
34,584
-30.2%
0.00%
-50.0%
Q4 2015$1,597,000
+1.9%
49,530
+2.1%
0.00%0.0%
Q3 2015$1,567,000
-24.3%
48,492
-3.1%
0.00%0.0%
Q2 2015$2,069,000
+25.9%
50,056
+36.8%
0.00%0.0%
Q1 2015$1,644,000
+23.2%
36,583
+2.6%
0.00%
+100.0%
Q4 2014$1,334,000
-23.7%
35,658
-28.8%
0.00%0.0%
Q3 2014$1,749,000
+52.1%
50,084
+53.6%
0.00%0.0%
Q2 2014$1,150,000
-77.7%
32,610
-79.4%
0.00%
-80.0%
Q1 2014$5,148,000
+180.9%
157,945
+263.1%
0.01%
+150.0%
Q4 2013$1,833,000
-59.8%
43,495
-61.9%
0.00%
-60.0%
Q3 2013$4,556,000
+14.3%
114,267
+18.5%
0.01%
+25.0%
Q2 2013$3,986,000
-0.1%
96,414
+0.6%
0.00%0.0%
Q1 2013$3,991,00095,7960.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders